News
HIV jab has signed a deal to supply the costly injection at a knock-down price to as many as two million people in poorer countries.
17h
AllAfrica on MSNGlobal Fund Secures Access to Breakthrough HIV Prevention Drug Lenacapavir for Low - and Middle-Income CountriesA pivotal moment in the fight to end AIDS -- ensuring lifesaving innovation reaches those who need it most, wherever they liveThe Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund) ...
In an interview with The News & Observer, Dr. Barton Haynes discusses the future of HIV vaccine development after HHS ...
Lower-income countries, including South Africa, gain unprecedented access to lenacapavir, a revolutionary HIV prevention drug ...
The FDA has approved a breakthrough preventative treatment for HIV that could change the course of the AIDS epidemic. But ...
Gilead has partnered with Global Fund to supply lenacapavir for the prevention of HIV as pre-exposure prophylaxis (PrEP).
A new report says the withdrawal of U.S. funding has caused a “systemic shock” to the global effort against AIDS and HIV.
HIV remains incurable but manageable. Johns Hopkins found a way to silence it long-term using a molecule from the virus ...
In a report released on Thursday, the UN body in charge of fighting HIV/Aids does not single out the US, but says that ...
HealthLink talked with a Seattle-based physician about why the newly approved drug could be a game-changer in preventing HIV.
11d
allAfrica.com on MSNFact-checked: HIV/Aids breakthrough not a ‘cure’, popular social media posts misrepresent the factsAfrica Check has debunked viral social media claims about an HIV “cure”, clarifying that the breakthrough is promising, but ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results